AAAAAA

   
Results: 1-6 |
Results: 6

Authors: Bocan, TMA Krause, BR Rosebury, WS Lu, XK Dagle, C Mueller, SB Auerbach, B Sliskovic, DR
Citation: Tma. Bocan et al., The combined effect of inhibiting both ACAT and HMG-CoA reductase may directly induce atherosclerotic lesion regression, ATHEROSCLER, 157(1), 2001, pp. 97-105

Authors: Peterson, JT Hallak, H Johnson, L Li, H O'Brien, PM Sliskovic, DR Bocan, TMA Coker, ML Etoh, T Spinale, FG
Citation: Jt. Peterson et al., Matrix metalloproteinase inhibition attenuates left ventricular remodelingand dysfunction in a rat model of progressive heart failure, CIRCULATION, 103(18), 2001, pp. 2303-2309

Authors: Bocan, TMA Krause, BR Rosebury, WS Mueller, SB Lu, XK Dagle, C Major, T Lathia, C Lee, H
Citation: Tma. Bocan et al., The ACAT inhibitor avasimibe reduces macrophages and matrix metalloproteinase expression in atherosclerotic lesions of hypercholesterolemic rabbits, ART THROM V, 20(1), 2000, pp. 70-79

Authors: Li, H Simon, H Bocan, TMA Peterson, JT
Citation: H. Li et al., MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition, CARDIO RES, 46(2), 2000, pp. 298-306

Authors: Ramharack, R Bocan, TMA Imperiale, MJ Spahr, MA
Citation: R. Ramharack et al., Recombinant adenovirus vector mediated expression of lipoprotein (a) [Lp(a)] in rabbit plasma, BBA-MOL C B, 1438(3), 1999, pp. 322-328

Authors: Sliskovic, DR Krause, BR Bocan, TMA
Citation: Dr. Sliskovic et al., Atherosclerosis: Emerging pharmacological approaches, ANNU REP M, 34, 1999, pp. 101-110
Risultati: 1-6 |